PlainPharmaWatch

CMS Open Payments · Program Year 2024

Organogenesis Inc.

Organogenesis Inc. reported $3,117,759.79 in payments to 24,238 physicians and teaching hospitals across 24,397 transactions.

See the rankings → How this is sourced
$3.1M
Total payments
24,397
Transactions
24,238
Recipients
+$116.4K
General Payments vs PY2023

Organogenesis Inc. reported $3,117,759.79 in payments to 24,238 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #354 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $128.63 per recipient across 7 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Organogenesis Inc. pairs top-quartile payment volume with an unusually diversified payment pattern across a wide recipient base.

#354
of 1,925 companies
0.0%
of all US industry payments
0.1%
paid to its single top recipient
7
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Organogenesis Inc.'s CMS-reported General Payments increased by $116.4K (+6.0%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: ORGANOGENESIS INC.PY2023: ORGANOGENESIS INC.PY2024: Organogenesis Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$1.9MPY2024$2.1M
PY2023
$1,936,263.91
PY2024
$2,052,705.02

How Organogenesis Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Organogenesis Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$3,117,760 Top 18% higher than 82% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). Below this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). This entry sits in this band. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Organogenesis Inc.

$3,117,759.79: that is what Organogenesis Inc. reported in payments to 24,238 physicians and teaching hospitals during Program Year 2024, spread across 24,397 transactions ($127.79 per transaction, $128.63 per recipient). The company sits at rank #354 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

23,220 transactions worth $739.1K make "Food and Beverage" the top general-payment category in the 7-category breakdown below, 23.7% of the reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Across 7 types of general payments, Organogenesis Inc.'s largest category was "Food and Beverage" at $739.1K - 23.7% of the company's reported total.

How Organogenesis Inc. divides its payments

General-payment categories, ordered by reported total

1. Food and Beverage$739.1K2. Compensation for Services…$705.1K3. Consulting Fee$445.3K4. Travel and Lodging$131.1K5. Space Rental or Facility …$22.6K6. Debt Forgiveness$6.5K7. Long-Term Medical Supply …$3.0K
Payment Type Amount Transactions
Food and Beverage $739.1K 23,220
Compensation for Services Other Than Consulting $705.1K 262
Consulting Fee $445.3K 70
Travel and Lodging $131.1K 670
Space Rental or Facility Fees $22.6K 9
Debt Forgiveness $6.5K 5
Long-Term Medical Supply or Device Loan $3.0K 2

Recipient Concentration in General Payments

The five largest recipient relationships account for $477,655.72 (23.3%) of $2,052,705.02 in this company's General Payments records across 9,104 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Organogenesis Inc.

The five named recipients with the highest reported General Payments from this company

Vipul Dev$135.6KAmy Tucker$119.2KScott James$84.0KRobert Clemency$78.7KDaniel Kapp$60.1K
  1. 1

    Vipul Dev

    $135,584.69 across 52 reported transactions

  2. 2

    Amy Tucker

    $119,175.42 across 151 reported transactions

  3. 3

    Scott James

    $84,049.24 across 8 reported transactions

  4. 4

    Robert Clemency

    $78,714.48 across 74 reported transactions

  5. 5

    Daniel Kapp

    $60,131.89 across 28 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $127.79. Average per recipient: $128.63.

Total Amount

$3,117,759.79

Avg per Transaction

$127.79

Avg per Recipient

$128.63

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Organogenesis Inc. Share

0.0%

#354 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Organogenesis Inc.

Amneal Pharmaceuticals LLC

$3.1M 20,418 recipients

Whip Mix Corporation

$3.1M 19 recipients

NeuraMedica Inc.

$3.1M 0 recipients

Array Biopharma Inc

$3.1M 8,513 recipients

BioFire Diagnostics, LLC

$3.1M 11 recipients

Sekisui Diagnostics, LLC

$3.2M 863 recipients

Frequently Asked Questions

How much did Organogenesis Inc. pay to physicians and hospitals in 2024? ▾
Organogenesis Inc. made $3,117,759.79 in payments to physicians and hospitals in Program Year 2024, across 24,397 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from Organogenesis Inc.? ▾
Averaging $128.63 per recipient, Organogenesis Inc.'s 2024 payments reached 24,238 physicians and teaching hospitals.
What types of payments did Organogenesis Inc. make? ▾
Organogenesis Inc. made 7 different types of general payments (consulting, meals, travel, and similar categories). The largest general-payment category was "Food and Beverage" at $739.1K, representing 23.7% of the company's reported total.
How does Organogenesis Inc. rank among pharmaceutical companies? ▾
By total payment amount, Organogenesis Inc. sits at #354 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Organogenesis Inc.? ▾
The average transaction from Organogenesis Inc. was $127.79 in 2024. The company made 24,397 total transactions to 24,238 recipients.
Where does the payment data for Organogenesis Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Organogenesis Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.